EFFECT OF OMEPRAZOLE ON CONCENTRATIONS OF CLARITHROMYCIN IN PLASMA AND GASTRIC TISSUE AT STEADY-STATE

被引:119
作者
GUSTAVSON, LE [1 ]
KAISER, JF [1 ]
EDMONDS, AL [1 ]
LOCKE, CS [1 ]
DEBARTOLO, ML [1 ]
SCHNECK, DW [1 ]
机构
[1] ABBOTT LABS,N CHICAGO,IL 60064
关键词
D O I
10.1128/AAC.39.9.2078
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study was conducted to determine (i) the effect of omeprazole on steady-state concentrations of clarithromycin and 14-(R)-hydroxyclarithromycin in plasma and gastric mucosa, (ii) the effect of clarithromycin on steady-state concentrations of omeprazole in plasma, and (iii) the effect of clarithromycin on the suppression of gastric acid secretion by omeprazole. Twenty healthy, Helicobacter pylori-negative male subjects completed this three-period, double-blind, randomized crossover study. In period 1, all subjects received 40 mg of omeprazole each morning for 6 days. Twenty-four-hour gastric pH monitoring took place on days -1 and 6. Pharmacokinetic sampling took place on day 6. In periods 2 and 3, subjects were randomly assigned to receive either 40 mg of omeprazole or omeprazole placebo daily for 6 days plus clarithromycin (500 mg) every 8 h for 5 days with a single 500-mg dose on day 6. Gastric tissue and mucus samples were obtained via endoscopy on day 5. Gastric pH monitoring and pharmacokinetic sampling took place on day 6. Two week washout intervals separated the three study periods. Clarithromycin increased mean omeprazole area under the concentration-time curve from 0 to 24 h from 3.3 +/- 2.0 to 6.3 +/- 4.5 mu g . h/ml (P < 0.05) and harmonic mean half-life from 1.2 to 1.6 h (P < 0.05) but did not significantly alter the effect of omeprazole on gastric pH. Mean clarithromycin area under the concentration-time curve from 0 to 8 h increased from 22.9 +/- 5.5 (placebo) to 26.4 +/- 5.7 mu g . h/ml (omeprazole) (P < 0.05) when clarithromycin was administered with omeprazole. Analysis of variance revealed that mean concentrations of clarithromycin in tissue and mucus were statistically significantly higher when clarithromycin was given with omeprazole than when clarithromycin was given with placebo (P < 0.001). Mean maximum observed concentrations of clarithromycin in the gastric fundus increased from 20.8 +/- 7.6 (placebo) to 24.3 +/- 6.4 mu g/g (omeprazole), and those in the gastric mucus increased from 4.2 +/- 7.7 (placebo) to 39.3 +/- 32.8 mu g/g (omeprazole), Similar increases were observed for the 14-(R)-hydroxyclarithromycin. These results show that omeprazole increases concentrations of clarithromycin in gastric tissue and mucus and may provide a mechanism for synergy between clarithromycin and omeprazole that explains the excellent eradication of H. pylori seen in clinical trials.
引用
收藏
页码:2078 / 2083
页数:6
相关论文
共 27 条
  • [1] SLOW OMEPRAZOLE METABOLIZERS ARE ALSO POOR S-MEPHENYTOIN HYDROXYLATORS
    ANDERSSON, T
    REGARDH, CG
    DAHLPUUSTINEN, ML
    BERTILSSON, L
    [J]. THERAPEUTIC DRUG MONITORING, 1990, 12 (04) : 415 - 416
  • [2] ATESHKADI A, 1993, CLIN PHARMACY, V12, P34
  • [3] ABSOLUTE BIOAVAILABILITY OF CLARITHROMYCIN AFTER ORAL-ADMINISTRATION IN HUMANS
    CHU, SY
    DEATON, R
    CAVANAUGH, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 1147 - 1150
  • [4] SIMULTANEOUS DETERMINATION OF CLARITHROMYCIN AND 14(R)-HYDROXYCLARITHROMYCIN IN PLASMA AND URINE USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION
    CHU, SY
    SENNELLO, LT
    SONDERS, RC
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 571 (1-2): : 199 - 208
  • [5] Curi-Pedrosa Rozangela, 1993, British Journal of Clinical Pharmacology, V36, p156P
  • [6] FERRINI G, 1992, IR J MED SCI S10, V161, P99
  • [7] GIBALDI M, 1975, PHARMACOKINETICS
  • [8] Gustavson L. E., 1993, Pharmaceutical Research (New York), V10, pS311
  • [9] CAMPYLOBACTER-PYLORIDIS AND GASTRITIS - ASSOCIATION WITH INTERCELLULAR SPACES AND ADAPTATION TO AN ENVIRONMENT OF MUCUS AS IMPORTANT FACTORS IN COLONIZATION OF THE GASTRIC EPITHELIUM
    HAZELL, SL
    LEE, A
    BRADY, L
    HENNESSY, W
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (04) : 658 - 663
  • [10] DETERMINATION OF LANSOPRAZOLE AND 5 METABOLITES IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    KAROL, MD
    GRANNEMAN, GR
    ALEXANDER, K
    [J]. JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 668 (01): : 182 - 186